These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 9020557

  • 21. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
    Bussels B, Maes A, Hermans R, Nuyts S, Weltens C, Van den Bogaert W.
    Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
    [Abstract] [Full Text] [Related]

  • 22. Radiation-induced hyposalivation and its treatment with oral pilocarpine.
    Niedermeier W, Matthaeus C, Meyer C, Staar S, Müller RP, Schulze HJ.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Nov; 86(5):541-9. PubMed ID: 9830645
    [Abstract] [Full Text] [Related]

  • 23. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):374-87. PubMed ID: 15380569
    [Abstract] [Full Text] [Related]

  • 24. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.
    Hey J, Setz J, Gerlach R, Vordermark D, Gernhardt CR, Kuhnt T.
    Int J Radiat Oncol Biol Phys; 2009 Dec 01; 75(5):1475-80. PubMed ID: 19515505
    [Abstract] [Full Text] [Related]

  • 25. Kininogen-kallikrein-kinin system in plasma and saliva of patients with Sjögren's syndrome.
    Hernández CC, Donadi EA, Reis ML.
    J Rheumatol; 1998 Dec 01; 25(12):2381-4. PubMed ID: 9858433
    [Abstract] [Full Text] [Related]

  • 26. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
    Nyárády Z, Németh A, Bán A, Mukics A, Nyárády J, Ember I, Olasz L.
    Anticancer Res; 2006 Dec 01; 26(2B):1557-62. PubMed ID: 16619571
    [Abstract] [Full Text] [Related]

  • 27. Oral pilocarpine (5mg t.i.d.) used for xerostomia causes adverse effects in Japanese.
    Nakamura N, Sasano N, Yamashita H, Igaki H, Shiraishi K, Terahara A, Asakage T, Nakao K, Ebihara Y, Ohtomo K, Nakagawa K.
    Auris Nasus Larynx; 2009 Jun 01; 36(3):310-3. PubMed ID: 18635328
    [Abstract] [Full Text] [Related]

  • 28. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
    Jellema AP, Doornaert P, Slotman BJ, Leemans CR, Langendijk JA.
    Radiother Oncol; 2005 Nov 01; 77(2):164-71. PubMed ID: 16256229
    [Abstract] [Full Text] [Related]

  • 29. Nerve-evoked secretion of immunoglobulin A in relation to other proteins by parotid glands in anaesthetized rat.
    Proctor GB, Carpenter GH, Anderson LC, Garrett JR.
    Exp Physiol; 2000 Sep 01; 85(5):511-8. PubMed ID: 11038402
    [Abstract] [Full Text] [Related]

  • 30. Levels of pre-kallikrein in resting and stimulated human parotid and submandibular saliva.
    Francis CA, Hector MP, Proctor GB.
    Eur J Oral Sci; 2001 Oct 01; 109(5):365-8. PubMed ID: 11695760
    [Abstract] [Full Text] [Related]

  • 31. Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site.
    Bhide S, Clark C, Harrington K, Nutting CM.
    Med Dosim; 2007 Oct 01; 32(3):188-95. PubMed ID: 17707198
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of irradiated salivary gland function in patients with head and neck tumours treated with radiotherapy.
    Baharudin A, Khairuddin A, Nizam A, Samsuddin AR.
    J Laryngol Otol; 2009 Jan 01; 123(1):108-13. PubMed ID: 18452635
    [Abstract] [Full Text] [Related]

  • 33. Kallikrein excretion in parotid saliva in rats with various forms of arterial hypertension.
    Schmid G, Dragoun GP, Wigand ME, Heidland A.
    Arch Otorhinolaryngol; 1979 Jan 01; 225(3):185-90. PubMed ID: 261642
    [Abstract] [Full Text] [Related]

  • 34. The effect of pilocarpine and biperiden on salivary secretion during and after radiotherapy in head and neck cancer patients.
    Rode M, Smid L, Budihna M, Soba E, Rode M, Gaspersic D.
    Int J Radiat Oncol Biol Phys; 1999 Sep 01; 45(2):373-8. PubMed ID: 10487558
    [Abstract] [Full Text] [Related]

  • 35. Parotid gland function following accelerated and conventionally fractionated radiotherapy.
    Leslie MD, Dische S.
    Radiother Oncol; 1991 Oct 01; 22(2):133-9. PubMed ID: 1957003
    [Abstract] [Full Text] [Related]

  • 36. Unilateral versus bilateral irradiation in squamous cell head and neck cancer in relation to patient-rated xerostomia and sticky saliva.
    Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA.
    Radiother Oncol; 2007 Oct 01; 85(1):83-9. PubMed ID: 17391790
    [Abstract] [Full Text] [Related]

  • 37. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.
    Barker JL, Garden AS, Ang KK, O'Daniel JC, Wang H, Court LE, Morrison WH, Rosenthal DI, Chao KS, Tucker SL, Mohan R, Dong L.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):960-70. PubMed ID: 15234029
    [Abstract] [Full Text] [Related]

  • 38. Long-term parotid gland function after radiotherapy.
    Braam PM, Roesink JM, Moerland MA, Raaijmakers CP, Schipper M, Terhaard CH.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):659-64. PubMed ID: 15936542
    [Abstract] [Full Text] [Related]

  • 39. Two-year longitudinal study of parotid salivary flow rates in head and neck cancer patients receiving unilateral neck parotid-sparing radiotherapy treatment.
    Henson BS, Eisbruch A, D'Hondt E, Ship JA.
    Oral Oncol; 1999 May 01; 35(3):234-41. PubMed ID: 10621842
    [Abstract] [Full Text] [Related]

  • 40. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T, Terhaard CH, Roesink JM, Braam PM, van Gils CH, Moerland MA, Raaijmakers CP.
    Int J Radiat Oncol Biol Phys; 2008 Nov 15; 72(4):1101-9. PubMed ID: 18472355
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.